Determination of chiral pharmaceuticals and illicit drugs in wastewater and sludge using microwave assisted extraction, solid-phase extraction and chiral liquid chromatography coupled with tandem mass spectrometry

Analytica Chimica Acta

Volumn 882, Issue , 2015, Pages 112-126

  Evans, Sian E ^a   Davies, Paul ^a   Lubben, Anneke ^a   Kasprzyk Hordern, Barbara ^a  

^a University of Bath   (United Kingdom)

Author keywords

Chiral chromatography coupled with mass spectrometry; Chiral drugs; Illicit; Pharmaceuticals; Sludge; Wastewater

Indexed keywords

DRUG PRODUCTS; EFFLUENTS; ENANTIOMERS; FILTRATION; LEAD REMOVAL (WATER TREATMENT); LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; PHASE SEPARATION; PLANTS (BOTANY); SEWAGE TREATMENT PLANTS; WASTEWATER; WASTEWATER TREATMENT;

CHIRAL CHROMATOGRAPHY; CHIRAL DRUGS; CHIRAL LIQUID CHROMATOGRAPHY; ILLICIT; MICROWAVE-ASSISTED EXTRACTION; PHARMACOLOGICALLY ACTIVE COMPOUNDS; SLUDGE; WASTEWATER TREATMENT PLANTS;

EXTRACTION;

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALPRENOLOL; AMPHETAMINE; ANTIDEPRESSANT AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; DESMETHYLVENLAFAXINE; EPHEDRINE; FLUOXETINE; ILLICIT DRUG; METHAMPHETAMINE; METOPROLOL; MEXILETINE; MIRTAZAPINE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; NORCITALOPRAM; NOREPHEDRINE; NORFLUOXETINE; PROPRANOLOL; PSEUDOEPHEDRINE; SALBUTAMOL; SOTALOL; TERBUTALINE; TRAMADOL; UNCLASSIFIED DRUG; VENLAFAXINE; DRUG; SEWAGE; STREET DRUG; WATER POLLUTANT;

ANALYTIC METHOD; ARTICLE; CHIRAL LIQUID CHROMATOGRAPHY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EFFLUENT; ENANTIOMERIC RATIO; LIQUID CHROMATOGRAPHY; MICROWAVE ASSISTED EXTRACTION; PRIORITY JOURNAL; SEPARATION TECHNIQUE; SLUDGE TREATMENT; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; WASTE WATER MANAGEMENT; WATER ANALYSIS; ANALYSIS; CHEMISTRY; MICROWAVE RADIATION; PROCEDURES; SEWAGE; STEREOISOMERISM; WATER POLLUTANT;

CHROMATOGRAPHY, LIQUID; MICROWAVES; PHARMACEUTICAL PREPARATIONS; SEWAGE; SOLID PHASE EXTRACTION; STEREOISOMERISM; STREET DRUGS; TANDEM MASS SPECTROMETRY; WATER POLLUTANTS, CHEMICAL;

EID: 84931574361     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2015.03.039     Document Type: Article

References (43)

1. Santos L.H.M.L.M., Gros M., Rodriguez-Mozaz S., Delerue-Matos C., Pena A., Barceló D., et al. Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals. Sci. Total Environ. 2013, 461-462:302-316.
2. Uslu M.O., Jasim S., Arvai A., Bewtra J., Biswas N. A survey of occurrence and risk assessment of pharmaceutical substances in the Great Lakes Basin. Ozone Sci. Eng. 2013, 35(July (1)):249-262.
3. Gamble A., Babbar-Sebens M. On the use of multivariate statistical methods for combining in-stream monitoring data and spatial analysis to characterize water quality conditions in the White River Basin, Indiana, USA. Environ. Monit. Assess. 2012, 184:845-875.
4. Krascsenits Z., Hiller E., Bartal M. Distribution of four human pharmaceuticals, carbamazepine, diclofenac, gemfibrozil, and ibuprofen between sediment and water. J. Hydrol. Hydromech. 2008, 56:237-246.
5. Schultz M.M., Furlong E.T., Kolpin D.W., Werner S.L., Schoenfuss H.L., Barber L.B., et al. Antidepressant pharmaceuticals in two U.S. effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue. Environ. Sci. Technol. 2010, 44:1918-1925. 2010/03/15.
6. Silva B.F.d., Jelic A., Lopez-Serna R., Mozeto A.A., Petrovic M., Barcelo D. Occurrence and distribution of pharmaceuticals in surface water, suspended solids and sediments of the Ebro River Basin, Spain. Chemosphere 2011, 85:1331-1339.
7. Langford K.H., Reid M., Thomas K.V. Multi-residue screening of prioritised human pharmaceuticals, illicit drugs and bactericides in sediments and sludge. J. Environ. Monit. 2011, 13(August):2284-2291.
8. Vazquez-Roig P., Andreu V., Onghena M., Blasco C., Pico Y. Assessment of the occurrence and distribution of pharmaceuticals in a Mediterranean wetland (L'Albufera, Valencia, Spain) by LC-MS/MS. Anal. Bioanal. Chem. 2011, 400(May):1287-1301.
9. Maskaoui K., Zhou J.L. Colloids as a sink for certain pharmaceuticals in the aquatic environment. Environ. Sci. Pollut. Res. 2010, 17:898-907.
10. Lahti M., Oikari A. Pharmaceuticals in settleable particulate material in urban and non-urban waters. Chemosphere 2011, 85:826-831.
11. Baker D.R., Kasprzyk-Hordern B. Multi-residue determination of the sorption of illicit drugs and pharmaceuticals to wastewater suspended particulate matter using pressurised liquid extraction, solid phase extraction and liquid chromatography coupled with tandem mass spectrometry. J. Chromatogr. A 2011, 1218(November (4)):7901-7913.
12. Lin K., Gan J. Sorption and degradation of wastewater-associated non-steroidal anti-inflammatory drugs and antibiotics in soils. Chemosphere 2011, 83(April):240-246.
13. Carballa M., Omil F., Lema J.M. Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage. Chemosphere 2008, 72:1118-1123.
14. Kasprzyk-Hordern B. Pharmacologically active compounds in the environment and their chirality. Chem. Soc. Rev. 2010, 39:4466-4503.
15. De Andres F., Castaneda G., Rios A. Use of toxicity assays for enantiomeric discrimination of pharmaceutical substances. Chirality 2009, 21(August):751-759.
16. Stanley J.K., Ramirez A.J., Mottaleb M., Chambliss C.K., Brooks B.W. Enantiospecific toxicity of the β-blocker propranolol to Daphnia magna and Pimephales promelas. Environ. Toxicol. Chem. 2006, 25:1780-1786.
17. Stanley J.K., Ramirez A.J., Chambliss C.K., Brooks B.W. Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. Chemosphere 2007, 69:9-16.
18. López-Serna R., Kasprzyk-Hordern B., Petrović M., Barceló D. Multi-residue enantiomeric analysis of pharmaceuticals and their active metabolites in the Guadalquivir River basin (South Spain) by chiral liquid chromatography coupled with tandem mass spectrometry. Anal. Bioanal. Chem. 2013, 1-15. 2013/04/12.
19. Kasprzyk-Hordern B., Baker D.R. Estimation of community-wide drugs use via stereoselective profiling of sewage. Sci. Total Environ. 2012, 423:142-150.
20. Kasprzyk-Hordern B., Baker D.R. Enantiomeric profiling of chiral drugs in wastewater and receiving waters. Environ. Sci. Technol. 2011, 46:1681-1691. 2012/02/07.
21. Fono L.J., Sedlak D.L. Use of the chiral pharmaceutical propranolol to identify sewage discharges into surface waters. Environ. Sci. Technol. 2005, 39:9244-9252. 2005/12/01.
22. Barclay V.K., Tyrefors N.L., Johansson I.M., Pettersson C.E. Trace analysis of fluoxetine and its metabolite norfluoxetine. Part II enantioselective quantification and studies of matrix effects in raw and treated wastewater by solid phase extraction and LC-MS/MS. J. Chromatogr. A 2012, 1227:105-114.
23. Barclay V.K., Tyrefors N.L., Johansson I.M., Pettersson C.E. Trace analysis of fluoxetine and its metabolite norfluoxetine. Part I development of a chiral liquid chromatography-tandem mass spectrometry method for wastewater samples. J. Chromatogr. A 2011, 1218:5587-5596.
24. MacLeod S.L., Wong C.S. Loadings, trends, comparisons, and fate of achiral and chiral pharmaceuticals in wastewaters from urban tertiary and rural aerated lagoon treatments. Water Res. 2010, 44(January):533-544.
25. MacLeod S.L., Sudhir P., Wong C.S. Stereoisomer analysis of wastewater-derived beta-blockers, selective serotonin re-uptake inhibitors, and salbutamol by high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2007, 1170(November (2)):23-33.
26. Nikolai L.N., McClure E.L., MacLeod S.L., Wong C.S. Stereoisomer quantification of the beta-blocker drugs atenolol, metoprolol, and propranolol in wastewaters by chiral high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2006, 1131(October (27)):103-109.
27. Bagnall J.P., Evans S.E., Wort M.T., Lubben A.T., Kaspryzyk-Hordern B. Using chiral liquid chromatography quadrupole time-of-flight mass spectrometry for the analysis of pharmaceuticals and illicit drugs in surface and wastewater at the enantiomeric level. J. Chromatogr. A 2012, 1249:115-129.
28. Gasser G., Pankratov I., Elhanany S., Werner P., Gun J., Gelman F., et al. Field and laboratory studies of the fate and enantiomeric enrichment of venlafaxine and O-desmethylvenlafaxine under aerobic and anaerobic conditions. Chemosphere 2012, 88:98-105.
29. Selke S., Scheurell M., Shah M.R., Huehnerfuss H. Identification and enantioselective gas chromatographic mass-spectrometric separation of O-desmethylnaproxen, the main metabolite of the drug naproxen, as a new environmental contaminant. J. Chromatogr. A 2010, 1217(January (15)):419-423.
30. Hashim N.H., Khan S.J. Enantioselective analysis of ibuprofen, ketoprofen and naproxen in wastewater and environmental water samples. J. Chromatogr. A 2011, 1218(July (22)):4746-4754.
31. Fono L.J., Kolodziej E.P., Sedlak D.L. Attenuation of wastewater-derived contaminants in an effluent-dominated river. Environ. Sci. Technol. 2006, 40(December (1)):7257-7262.
32. Buser H.-R., Poiger T., Müller M.D. Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ. Sci. Technol. 1999, 33:2529-2535. 1999/08/01.
33. Matamoros V., Hijosa M., Bayona J.M. Assessment of the pharmaceutical active compounds removal in wastewater treatment systems at enantiomeric level. Ibuprofen and naproxen. Chemosphere 2009, 75:200-205.
34. Huang Q., Zhang K., Wang Z., Wang C., Peng X. Enantiomeric determination of azole antifungals in wastewater and sludge by liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 2012, 403(June):1751-1760.
35. Chromtech., Instruction Manual - Chiral CBH. , 2001. http://www.bgb-analytik.de/pdf/Chromtech%20Chirale%20Applikationen/Anleitungen/IN_CBH.pdf.
36. Implementing council directive 96/23/EC concerning the performance of analytical methods and the interpretation of results, ed: Official Journal of the European Communities, 2002.
37. Ribeiro A.R., Afonso C.M., Castro P.M.L., Tiritan M.E. Enantioselective biodegradation of pharmaceuticals, alprenolol and propranolol, by an activated sludge inoculum. Ecotoxicol. Environ. Saf. 2012, 87(January (1)):108-114.
38. Kosel M., Eap C.B., Amey M., Baumann P. Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography. J. Chromatogr. B 1998, 719(November (20)):234-238.
39. da Fonseca P., Bonato P.S. Chiral HPLC analysis of venlafaxine metabolites in rat liver microsomal preparations after LPME extraction and application to an in vitro biotransformation study. Anal. Bioanal. Chem. 2010, 396(January):817-824.
40. Jensen B.P., Sharp C.F., Gardiner S.J., Begg E.J. Development and validation of a stereoselective liquid chromatography-tandem mass spectrometry assay for quantification of S- and R-metoprolol in human plasma. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2008, 865(April (1)):48-54.
41. Rao R.N., Kumar K.N., Ramakrishna S. Enantiomeric separation of mirtazapine and its metabolite in rat plasma by reverse polar ionic liquid chromatography using fluorescence and polarimetric detectors connected in series. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2011, 879(July (1)):1911-1916.
42. Wu J., Ding C., Ge Q., Li Z., Zhou Z., Zhi X. Simultaneous determination of ipratropium and salbutamol in rat plasma by LC-MS/MS and its application to a pharmacokinetic study. J. Chromatogr. B 2011, 879:3475-3483.
43. Luo W., Zhu L., Deng J., Liu A., Guo B., Tan W., et al. Simultaneous analysis of bambuterol and its active metabolite terbutaline enantiomers in rat plasma by chiral liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 2010, 52:227-231.